Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

V Grunwald; D Pink; G Egerer; E Schalk; Marinela Augustin; CKW Deinzer; V Kob; D Reichert; M Kebenko; S Brandl; D Hahn; LH Lindner; M Hoiczyk; U Ringsdorf; LC Hanker; D Hempel; B De Rivas; T Wismann; P Ivanyi

doi:10.3390/cancers14215234

Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

V Grunwald, D Pink, G Egerer, E Schalk, Marinela Augustin (Co-Autor/-in), CKW Deinzer, V Kob, D Reichert, M Kebenko, S Brandl, D Hahn, LH Lindner, M Hoiczyk, U Ringsdorf, LC Hanker, D Hempel, B De Rivas, T Wismann, P Ivanyi

Universitätsklinik für Innere Medizin 5 - Onkologie und Hämatologie

Publikation: Beitrag in Fachzeitschrift › Originalarbeit (Zeitschrift) › Begutachtung

3 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	5234
Fachzeitschrift	Cancers
Jahrgang	14
Ausgabenummer	21
DOIs	https://doi.org/10.3390/cancers14215234
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.3390/cancers14215234

Dieses zitieren

Grunwald, V., Pink, D., Egerer, G., Schalk, E., Augustin, M., Deinzer, CKW., Kob, V., Reichert, D., Kebenko, M., Brandl, S., Hahn, D., Lindner, LH., Hoiczyk, M., Ringsdorf, U., Hanker, LC., Hempel, D., De Rivas, B., Wismann, T., & Ivanyi, P. (2022). Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial. Cancers, 14(21), 5234. https://doi.org/10.3390/cancers14215234

@article{26b9e7296031484ea352d7388182b105,

title = "Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial",

keywords = "METASTATIC LIPOSARCOMA, SUPPORTIVE CARE, CHEMOTHERAPY, MECHANISM, EFFICACY, SAFETY, LEIOMYOSARCOMA, FAILURE",

author = "V Grunwald and D Pink and G Egerer and E Schalk and Marinela Augustin and CKW Deinzer and V Kob and D Reichert and M Kebenko and S Brandl and D Hahn and LH Lindner and M Hoiczyk and U Ringsdorf and LC Hanker and D Hempel and {De Rivas}, B and T Wismann and P Ivanyi",

note = "Augustin: Klinikum N{\"u}rnberg Nord, Schwerpunkt Onkologie/H{\"a}matologie, Klinik f{\"u}r Innere Medizin 5, Paracelsus Medizinische Privatuniversit{\"a}t, 90419 N{\"u}rnberg, Germany",

year = "2022",

doi = "10.3390/cancers14215234",

language = "English",

volume = "14",

pages = "5234",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "21",

}

Grunwald, V, Pink, D, Egerer, G, Schalk, E, Augustin, M, Deinzer, CKW, Kob, V, Reichert, D, Kebenko, M, Brandl, S, Hahn, D, Lindner, LH, Hoiczyk, M, Ringsdorf, U, Hanker, LC, Hempel, D, De Rivas, B, Wismann, T & Ivanyi, P 2022, 'Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial', Cancers, Jg. 14, Nr. 21, S. 5234. https://doi.org/10.3390/cancers14215234

TY - JOUR

T1 - Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Prospective, Multicenter, Phase IV Trial

AU - Grunwald, V

AU - Pink, D

AU - Egerer, G

AU - Schalk, E

AU - Augustin, Marinela

AU - Deinzer, CKW

AU - Kob, V

AU - Reichert, D

AU - Kebenko, M

AU - Brandl, S

AU - Hahn, D

AU - Lindner, LH

AU - Hoiczyk, M

AU - Ringsdorf, U

AU - Hanker, LC

AU - Hempel, D

AU - De Rivas, B

AU - Wismann, T

AU - Ivanyi, P

N1 - Augustin: Klinikum Nürnberg Nord, Schwerpunkt Onkologie/Hämatologie, Klinik für Innere Medizin 5, Paracelsus Medizinische Privatuniversität, 90419 Nürnberg, Germany

PY - 2022

Y1 - 2022

KW - METASTATIC LIPOSARCOMA

KW - SUPPORTIVE CARE

KW - CHEMOTHERAPY

KW - MECHANISM

KW - EFFICACY

KW - SAFETY

KW - LEIOMYOSARCOMA

KW - FAILURE

U2 - 10.3390/cancers14215234

DO - 10.3390/cancers14215234

M3 - Original Article (Journal)

C2 - 36358652

SN - 2072-6694

VL - 14

SP - 5234

JO - Cancers

JF - Cancers

IS - 21

ER -